Because HFDs and metabolic syndromes are well‐documented to elevate FFA levels, our findings provide a potential explanation for the potential of HFDs and metabolic syndromes to worsen diseases.[7, 8] Given the roles of cGAS, these results suggest possible metabolic information to improve therapeutic strategies and patient prognostication. The gene discussed is CGAS; the disease is metabolic syndrome.